Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease

Eduardo De Marchena, Simon Chakko, Pedro Fernandez, Augusto Villa, Debbie Cooper, Paula Wozniak, Jose Cruz, Richard J Thurer, Kenneth M. Kessler, Robert J Myerburg

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Clinical outcome was analyzed among a group of 39 consecutive patients with coronary artery disease, left ventricular (LV) ejection fractions <30% and arrhythmias that required an automatic implantable cardioverter defibrillator (AICD) in an attempt to better define the role of the device in patients with severely depressed LV function. Twenty-nine (74%) were survivors of out-of-hospital cardiac arrest and 10 (26%) had ventricular tachycardia that was refractory to electrophysiologically guided antiarrhythmic therapy. The study group had the following demographic characteristics: 90% were men, mean age was 64 years (range 41 to 79) and mean LV ejection fraction was 21 ± 4%. Concomitant pharmacotherapy included antiarrhythmic drugs in 31 (79%), vasodilators in 22 (56%) and digoxin in 20 (51%). There was no statistical difference in baseline characteristics between survivors and nonsurvivors. Patients were followed for a mean of 24 months (range 2 to 72) from implantation. The difference between actuarial survival-77% at 1 year and 72% at 2 years-and projected survival without the AICD (patients who survive without appropriate device discharge)-30% at 1 year and 21% at 2 years-was significant (p < 0.01 and <0.05 at 1 and 2 years, respectively). This study suggests that the AICD improves survival in patients with coronary artery disease despite severely depressed LV function.

Original languageEnglish
Pages (from-to)812-816
Number of pages5
JournalThe American journal of cardiology
Volume67
Issue number9
DOIs
StatePublished - Apr 15 1991

Fingerprint

Implantable Defibrillators
Left Ventricular Function
Coronary Artery Disease
Survival
Stroke Volume
Survivors
Out-of-Hospital Cardiac Arrest
Equipment and Supplies
Anti-Arrhythmia Agents
Digoxin
Ventricular Tachycardia
Vasodilator Agents
Cardiac Arrhythmias
Demography
Drug Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease. / De Marchena, Eduardo; Chakko, Simon; Fernandez, Pedro; Villa, Augusto; Cooper, Debbie; Wozniak, Paula; Cruz, Jose; Thurer, Richard J; Kessler, Kenneth M.; Myerburg, Robert J.

In: The American journal of cardiology, Vol. 67, No. 9, 15.04.1991, p. 812-816.

Research output: Contribution to journalArticle

De Marchena, Eduardo ; Chakko, Simon ; Fernandez, Pedro ; Villa, Augusto ; Cooper, Debbie ; Wozniak, Paula ; Cruz, Jose ; Thurer, Richard J ; Kessler, Kenneth M. ; Myerburg, Robert J. / Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease. In: The American journal of cardiology. 1991 ; Vol. 67, No. 9. pp. 812-816.
@article{6c1acbc2f1934a5aa5773a7f2bda5a9d,
title = "Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease",
abstract = "Clinical outcome was analyzed among a group of 39 consecutive patients with coronary artery disease, left ventricular (LV) ejection fractions <30{\%} and arrhythmias that required an automatic implantable cardioverter defibrillator (AICD) in an attempt to better define the role of the device in patients with severely depressed LV function. Twenty-nine (74{\%}) were survivors of out-of-hospital cardiac arrest and 10 (26{\%}) had ventricular tachycardia that was refractory to electrophysiologically guided antiarrhythmic therapy. The study group had the following demographic characteristics: 90{\%} were men, mean age was 64 years (range 41 to 79) and mean LV ejection fraction was 21 ± 4{\%}. Concomitant pharmacotherapy included antiarrhythmic drugs in 31 (79{\%}), vasodilators in 22 (56{\%}) and digoxin in 20 (51{\%}). There was no statistical difference in baseline characteristics between survivors and nonsurvivors. Patients were followed for a mean of 24 months (range 2 to 72) from implantation. The difference between actuarial survival-77{\%} at 1 year and 72{\%} at 2 years-and projected survival without the AICD (patients who survive without appropriate device discharge)-30{\%} at 1 year and 21{\%} at 2 years-was significant (p < 0.01 and <0.05 at 1 and 2 years, respectively). This study suggests that the AICD improves survival in patients with coronary artery disease despite severely depressed LV function.",
author = "{De Marchena}, Eduardo and Simon Chakko and Pedro Fernandez and Augusto Villa and Debbie Cooper and Paula Wozniak and Jose Cruz and Thurer, {Richard J} and Kessler, {Kenneth M.} and Myerburg, {Robert J}",
year = "1991",
month = "4",
day = "15",
doi = "10.1016/0002-9149(91)90612-O",
language = "English",
volume = "67",
pages = "812--816",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease

AU - De Marchena, Eduardo

AU - Chakko, Simon

AU - Fernandez, Pedro

AU - Villa, Augusto

AU - Cooper, Debbie

AU - Wozniak, Paula

AU - Cruz, Jose

AU - Thurer, Richard J

AU - Kessler, Kenneth M.

AU - Myerburg, Robert J

PY - 1991/4/15

Y1 - 1991/4/15

N2 - Clinical outcome was analyzed among a group of 39 consecutive patients with coronary artery disease, left ventricular (LV) ejection fractions <30% and arrhythmias that required an automatic implantable cardioverter defibrillator (AICD) in an attempt to better define the role of the device in patients with severely depressed LV function. Twenty-nine (74%) were survivors of out-of-hospital cardiac arrest and 10 (26%) had ventricular tachycardia that was refractory to electrophysiologically guided antiarrhythmic therapy. The study group had the following demographic characteristics: 90% were men, mean age was 64 years (range 41 to 79) and mean LV ejection fraction was 21 ± 4%. Concomitant pharmacotherapy included antiarrhythmic drugs in 31 (79%), vasodilators in 22 (56%) and digoxin in 20 (51%). There was no statistical difference in baseline characteristics between survivors and nonsurvivors. Patients were followed for a mean of 24 months (range 2 to 72) from implantation. The difference between actuarial survival-77% at 1 year and 72% at 2 years-and projected survival without the AICD (patients who survive without appropriate device discharge)-30% at 1 year and 21% at 2 years-was significant (p < 0.01 and <0.05 at 1 and 2 years, respectively). This study suggests that the AICD improves survival in patients with coronary artery disease despite severely depressed LV function.

AB - Clinical outcome was analyzed among a group of 39 consecutive patients with coronary artery disease, left ventricular (LV) ejection fractions <30% and arrhythmias that required an automatic implantable cardioverter defibrillator (AICD) in an attempt to better define the role of the device in patients with severely depressed LV function. Twenty-nine (74%) were survivors of out-of-hospital cardiac arrest and 10 (26%) had ventricular tachycardia that was refractory to electrophysiologically guided antiarrhythmic therapy. The study group had the following demographic characteristics: 90% were men, mean age was 64 years (range 41 to 79) and mean LV ejection fraction was 21 ± 4%. Concomitant pharmacotherapy included antiarrhythmic drugs in 31 (79%), vasodilators in 22 (56%) and digoxin in 20 (51%). There was no statistical difference in baseline characteristics between survivors and nonsurvivors. Patients were followed for a mean of 24 months (range 2 to 72) from implantation. The difference between actuarial survival-77% at 1 year and 72% at 2 years-and projected survival without the AICD (patients who survive without appropriate device discharge)-30% at 1 year and 21% at 2 years-was significant (p < 0.01 and <0.05 at 1 and 2 years, respectively). This study suggests that the AICD improves survival in patients with coronary artery disease despite severely depressed LV function.

UR - http://www.scopus.com/inward/record.url?scp=0025853101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025853101&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(91)90612-O

DO - 10.1016/0002-9149(91)90612-O

M3 - Article

C2 - 2011982

AN - SCOPUS:0025853101

VL - 67

SP - 812

EP - 816

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -